SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Laws ER, Parney IF, Huang W, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg. 2003; 99: 467473.
  • 2
    Curran WJ Jr., Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993; 85: 704710.
  • 3
    Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997; 37: 745751.
  • 4
    Maly RC, Leake B, Silliman RA. Health care disparities in older patients with breast carcinoma: informational support from physicians. Cancer. 2003; 97: 15171527.
  • 5
    Gagnon B, Mayo NE, Hanley J, MacDonald N. Pattern of care at the end of life: does age make a difference in what happens to women with breast cancer? J Clin Oncol. 2004; 22: 34583465.
  • 6
    Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr., Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999; 341: 20612067.
  • 7
    United Nations. World population ageing 1950–2050. New York: United Nations Population Division, 2002.
  • 8
    Anderson GF, Hussey PS. Health and population aging: a multinational comparison. New York: Commonwealth Fund, 1999.
  • 9
    Brandes AA, Monfardini S. The treatment of elderly patients with high-grade gliomas. Semin Oncol. 2003: 30(Suppl 19): 5862.
  • 10
    Lutterbach J, Weigel P, Guttenberger R, Hinkelbein W. Accelerated hyperfractionated radiotherapy in 149 patients with glioblastomas multiforme. Radiother Oncol. 1999; 53: 4952.
  • 11
    Lutterbach J, Sauerbrei W, Guttenberger R. Multivariate analysis of prognostic factors in patients with glioblastomas. Strahlenther Onkol. 2003; 179: 815.
  • 12
    Lutterbach J, Bartelt S, Stancu E, Guttenberger R. Patients with brain metastases: hope for recursive partitioning analysis (RPA) class 3. Radiother Oncol. 2002; 63: 339345.
  • 13
    Krzyzanowska MK, Weeks JC, Earle CC. Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness. J Clin Oncol. 2003; 21: 34093414.
  • 14
    Surawicz TS, Davis F, Freels S, Laws ER Jr., Menck HR. Brain tumor survival: results from the National Cancer Data Base. J Neurooncol. 1998; 40: 151160.
  • 15
    Stenning SP. Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party. J Neurooncol. 1990; 9: 4755.
  • 16
    Ohgaki H, Dessen P, Jourde B, et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res. 2004; 64: 68926899.
  • 17
    Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastomas multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001; 95: 190198.
  • 18
    Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys. 1999; 43: 795803.
  • 19
    Steinfeld AD, Donahue B, Walker I. Delay in the diagnosis of glioblastoma multiforme: is age a factor? Cancer Invest. 1996; 14: 317319.
  • 20
    Lowry JK, Snyder JJ, Lowry PW. Brain tumors in the elderly: recent trends in a Minnesota cohort study. Arch Neurol. 1998; 55: 922928.
  • 21
    Cowan JA Jr., Dimick JB, Leveque JC, Thompson BG, Upchurch GR Jr., Hoff JT. The impact of provider volume on mortality after intracranial tumor resection. Neurosurgery. 2003; 52: 4853.
  • 22
    Long DM, Gordon T, Bowman H, et al. Outcome and cost of craniotomy performed to treat tumors in regional academic referral centers. Neurosurgery. 2003; 52: 10561063.
  • 23
    Paszat L, Laperriere N, Groome P, Schulze K, Mackillop W, Holowaty E. A population-based study of glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2001; 51: 1001007.
  • 24
    Mahaley MS Jr., Mettlin C, Natarajan N, Laws ER Jr., Peace BB. National survey of patterns of care for brain-tumor patients. J Neurosurg. 1989; 71: 826836.
  • 25
    McKeever PE, Junck L, Strawderman MS, et al. Proliferation index is related to patient age in glioblastoma. Neurology. 2001; 56: 12161218.
  • 26
    Barker FG 2nd, Simmons ML, Chang SM, et al. EGFR overexpression and radiation response in glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2001; 51: 410418.
  • 27
    Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Clin Cancer Res. 2001; 43754381.
  • 28
    Petersen C, Petersen S, Milas L, Lang FF, Tofilon PJ. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Cancer Res. 2000; 6: 25132520.
  • 29
    Vuorinen V, Hinkka S, Farkkila M, Jaaskelainen J. Debulking or biopsy of malignant glioma in elderly people—a randomised study. Acta Neurochir (Wien). 2003; 145: 510.